Institutional Ownership Esperion Therapeutics, Inc. (ESPR)
This table provides information about the institutional ownership of Esperion Therapeutics, Inc. (ESPR). We have compiled data on the 215 institutions that hold shares in the stock, with a total of 129 Million shares, which have been reported (via 13F filing form) to have a value of $239 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Wasatch Advisors Inc
Salt Lake City, UT |
Feb 13, 2025 Q4 2024 |
24,482,258
shares
|
$44.6 Million
0.27% of portfolio
|
Q4 2024
Added 4.87%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
13,983,662
shares
|
$25.5 Million
0.0% of portfolio
|
Q2 2024
Added 392.59%
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
11,715,748
shares
|
$21.3 Million
0.0% of portfolio
|
Q4 2024
Reduced 10.18%
|
|
Bellevue Group Ag
Kuesnacht, V8 |
Feb 14, 2025 Q4 2024 |
9,944,064
shares
|
$18.1 Million
0.44% of portfolio
|
Q1 2024
Added 136.52%
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
6,309,377
shares
|
$11.5 Million
0.0% of portfolio
|
Q4 2024
Added 138.43%
|
|
Two Seas Capital LP
Rye, NY |
Feb 14, 2025 Q4 2024 |
6,230,871
shares
|
$11.3 Million
2.25% of portfolio
|
Q4 2024
Reduced 5.37%
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
4,504,234
shares
|
$8.2 Million
0.0% of portfolio
|
Q4 2024
Added 16.86%
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
4,339,948
shares
|
$7.9 Million
0.0% of portfolio
|
Q4 2024
Added 0.2%
|
|
Meditor Group LTD
|
Oct 07, 2024 Q3 2024 |
3,791,300
shares
|
$6.9 Million
12.99% of portfolio
|
Q3 2023
Reduced 13.89%
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Feb 14, 2025 Q4 2024 |
3,616,200
shares
|
$6.58 Million
0.02% of portfolio
|
Q4 2024
Added 0.45%
|
|
Two Sigma Investments, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
3,540,361
shares
|
$6.44 Million
0.02% of portfolio
|
Q4 2024
Reduced 2.34%
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
3,119,253
shares
|
$5.68 Million
0.0% of portfolio
|
Q4 2024
Added 48.61%
|
|
Indaba Capital Management, L.P.
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
3,000,000
shares
|
$5.46 Million
12.97% of portfolio
|
Q4 2024
New holding
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
2,753,260
shares
|
$5.01 Million
0.0% of portfolio
|
Q4 2024
Added 110.55%
|
|
Jpmorgan Chase & CO
New York, NY |
Feb 12, 2025 Q4 2024 |
2,454,216
shares
|
$4.47 Million
0.0% of portfolio
|
Q4 2024
Added 18.61%
|
|
Rhenman & Partners Asset Management Ab
Stockholm, V7 |
Feb 13, 2025 Q4 2024 |
1,915,000
shares
|
$3.49 Million
0.44% of portfolio
|
Q4 2024
Reduced 3.04%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
1,754,632
shares
|
$3.19 Million
0.0% of portfolio
|
Q4 2024
Added 1213.19%
|
|
Bank Of America Corp
Charlotte, NC |
Feb 14, 2025 Q4 2024 |
1,629,980
shares
|
$2.97 Million
0.0% of portfolio
|
Q4 2024
Added 45.07%
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
1,540,084
shares
|
$2.8 Million
0.0% of portfolio
|
Q4 2024
Added 4.45%
|
|
Woodline Partners LP
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
1,503,746
shares
|
$2.74 Million
0.02% of portfolio
|
Q4 2024
Reduced 33.0%
|
|
Center Book Partners LP
Greenwich, CT |
Feb 13, 2025 Q4 2024 |
1,306,259
shares
|
$2.38 Million
0.19% of portfolio
|
Q4 2024
Reduced 58.03%
|
|
Connor, Clark & Lunn Investment Management Ltd.
|
Feb 10, 2025 Q4 2024 |
932,008
shares
|
$1.7 Million
0.01% of portfolio
|
Q4 2024
Added 31.03%
|
|
Ubs Group Ag
|
Feb 14, 2025 Q4 2024 |
876,942
shares
|
$1.6 Million
0.0% of portfolio
|
Q4 2024
Added 871.22%
|
|
Platinum Investment Management LTD
Sydney Australia 2000, C3 |
Feb 10, 2025 Q4 2024 |
840,052
shares
|
$1.53 Million
0.11% of portfolio
|
Q4 2024
Reduced 23.13%
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Feb 14, 2025 Q4 2024 |
829,885
shares
|
$1.51 Million
0.0% of portfolio
|
Q4 2024
Reduced 75.62%
|